Which former NC Vermont News area high school standouts will be in action on Saturday, April 26?

Hayden Roberge and Nate Groff -
Hayden Roberge and Nate Groff -
0Comments

These former NC Vermont News area high school standouts will be in action on Saturday, April 26.

Hayden Roberge and Nate Groff -
Ben Alekson
Fairfield Stags
Right handed pitcher
Sophomore
6′2″ 200
Stowe High School
Hometown: Stowe
Next Game: vs. Quinnipiac Bobcats, Saturday, April 26, 1 p.m.

Hayden Roberge and Nate Groff -
Hayden Roberge
Post Eagles
Outfielder and first baseman
Graduate
5′11″ 210
U-32 High School (uhsd #32)
Hometown: Middlesex
Next Game: vs. Dominican Chargers, Saturday, April 26, 12 p.m.

Hayden Roberge and Nate Groff -
Nate Groff
Beloit Buccaneers
Freshman
Montpelier High School
Hometown: Montpelier
Next Game: vs. Monmouth Fighting Scots, Saturday, April 26, 12 p.m.

Hayden Roberge and Nate Groff -
Shane Starr
Franklin Pierce Ravens
Outfielder
Freshman
6′0″ 190
U-32 High School (uhsd #32)
Hometown: Moretown
Next Game: vs. American International Yellow Jackets, Saturday, April 26, 12 p.m.



Related

Lisa Hango, Vermont State Representative for the Franklin-5 District

Vermont lawmaker discusses legislative session delays and bill volume concerns

Vermont State Representative Lisa Hango reports continued delays at an extended legislative session as key budget-related bills remain unresolved. Hango highlights concerns about high bill volume and associated costs while discussing recent committee actions.

Sara Brenner, Principal Deputy Commissioner at FDA

FDA conducted inspection of 1 company in cities located in Washington County in 2025

There was one company in a city associated with Washington County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

1 company in a city within Lamoille County received one inspection in 2025

There was one company in a city associated with Lamoille County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.